LFWD
HEALTHCARELifeward Ltd
$7.00+0.00 (+0.00%)PRE
Live · NASDAQ · May 9, Close
AI Insight
What's Moving LFWD Today?
No stock-specific AI insight has been generated for LFWD yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$4.14$17.76
$7.00
Fundamentals
Market Cap$19M
P/E Ratio—
EPS$-17.16
Dividend Yield—
Dividend / Share—
ROE-1.5%
Profit Margin-0.9%
Debt / Equity—
Trading
Volume6K
Avg Volume (10D)—
Shares Outstanding2.8M
LFWD News
20 articles- CryoPort, Inc. (CYRX) Reports Q1 Loss, Tops Revenue EstimatesYahoo Finance·May 4, 2026
- Lifeward Announces New ReWalk® Data Presented at ASIA 2026 Conference Demonstrating a Comprehensive Longitudinal Safety Analysis for a Powered ExoskeletonYahoo Finance·May 4, 2026
- Lifeward Successfully Closes on Strategic Partnership with OramedYahoo Finance·Mar 25, 2026
- Lifeward Ltd (LFWD) Q4 2025 Earnings Call Highlights: Strategic Moves and Market ChallengesYahoo Finance·Mar 18, 2026
- Lifeward: Q4 Earnings SnapshotYahoo Finance·Mar 18, 2026
- Lifeward Reports Fourth Quarter and Full Year 2025 Financial ResultsYahoo Finance·Mar 18, 2026
- Lifeward Ltd (LFWD) Q4 2025: Everything You Need To Know Ahead Of EarningsYahoo Finance·Mar 17, 2026
- Lifeward Receives Shareholder Approval to Close on Strategic Partnership with Oramed—Creating Diversified Biomedical CompanyYahoo Finance·Mar 13, 2026
- Lifeward Regains Compliance with Nasdaq Minimum Bid Price RequirementYahoo Finance·Mar 11, 2026
- Lifeward to Report Fourth Quarter and Full Year 2025 Financial Results on March 18, 2026Yahoo Finance·Mar 10, 2026
- Lifeward Announces Collaboration With Shirley Ryan AbilityLab to Expand Access for the ReWalk Personal ExoskeletonYahoo Finance·Mar 2, 2026
- ORMP: Enabling Participation in Both ORMP & LFWD Businesses Expected to Enhance Shareholder ValueYahoo Finance·Feb 26, 2026
- Lifeward to Acquire Powered Upper Body Exoskeleton with AI Capabilities Designed to Restore Function to Stroke SurvivorsYahoo Finance·Feb 25, 2026
- Lifeward Announces Reverse Share SplitYahoo Finance·Feb 20, 2026
- Lifeward’s ReWalk™ Personal Exoskeleton Now Covered by Aetna, Coverage Expands to Include Three of the Largest Medicare Advantage InsurersYahoo Finance·Feb 17, 2026
- Lifeward Enters Transformative Strategic Investment and Partnership Agreement with Oramed to Create a Diversified Biomedical Innovation CompanyYahoo Finance·Jan 13, 2026
- Oramed and Lifeward Announce Strategic TransactionYahoo Finance·Jan 13, 2026
- Lifeward Appoints Bob Marshall as Chairman of the BoardYahoo Finance·Dec 19, 2025
- Lifeward Expands International Distribution of its ReWalk® Personal Robotic Exoskeleton into Mexico, Thailand, and the United Arab EmiratesYahoo Finance·Dec 17, 2025
- Lifeward Broadens Reimbursement Coverage for ReWalk 7 Personal Robotic Exoskeleton as Humana Medicare Advantage Plan Issues Prior Authorization ApprovalYahoo Finance·Dec 3, 2025
All 20 articles loaded
Price Data
Open$6.98
Previous Close$7.00
Day High$7.00
Day Low$6.94
52 Week High$17.76
52 Week Low$4.14
52-Week Range
$4.14$17.76
$7.00
Fundamentals
Market Cap$19M
P/E Ratio—
EPS$-17.16
Dividend Yield—
Dividend / Share—
ROE-1.5%
Profit Margin-0.9%
Debt / Equity—
Trading
Volume6K
Avg Volume (10D)—
Shares Outstanding2.8M
About Lifeward Ltd
ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes robotic exoskeletons for individuals with mobility impairments or other medical conditions in the United States, Europe, the Asia-Pacific, and Africa. The company is headquartered in Yokneam Illit, Israel.
HEALTHCAREMEDICAL DEVICES
Company Details
Security TypeStock
ExchangeNASDAQ
CurrencyUSD
Round Lot—
SICMEDICAL DEVICES
CIK—
Composite FIGI—
Share Class FIGI—